讯飞医疗科技 02506 Prospectus Information

IPO Timeline

Broker Deadline

2024-12-23

Morning deadline

HKEX Deadline

2024-12-23

Noon deadline

Broker Results (T-2)

2024-12-24

Some brokers release in afternoon

Grey Market (T-1)

2024-12-27

Afternoon

HKEX Allotment (T-1)

2024-12-27

Evening

Registrar Allotment (T-1)

2024-12-27

Evening

Listing Day (T)

2024-12-30

First day of trading

Company Overview

Stock Name	讯飞医疗科技
Stock Code	02506
Company Full Name	讯飞医疗科技
Industry	軟件服務
Principal Activities	公司是一家人工智能賦能的醫療解決方案提供商。
Listing Date	2024-12-30
Listing Rules Era	Old Rules
Listing Rules Chapter	To be extracted
Weighted Voting Rights (WVR)	No
Registered Address (Mainland China)	中國北京市西城區廣安門內大街167號
Business Address (Hong Kong)	To be extracted
Place of Incorporation	To be extracted
Listing Method	To be extracted
Listing Board	Main Board
Website	https://www.iflyhealth.com/
Share Registrar	卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact	(852)2980 1333
A-Share/US Dual Listing	No

Offering Information

Offering Mechanism	To be extracted
Offer Price	HK$ 82.80 / shares
Offer Price Range	Final offer price only, no range
Lot Size	To be extracted
Entry Threshold	To be extracted
Par Value	To be extracted
Offer Period	To be extracted
Global Offering Shares	To be extracted
HK Public Offer Shares (Initial)	To be extracted
Public Offer Lots (Initial)	To be extracted
International Placing Shares (Initial)	To be extracted
Offer Ratio	To be extracted
Total Shares Post-IPO	To be extracted
Greenshoe (Over-allotment Option)	No
Stabilizing Manager (Greenshoe)	—
Cornerstone Share	47.5%
Clawback Tiers	To be extracted
Reallocation Option	No
Total Global Offering Size	HK$ 58,258,080

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A

Lots Subscribed	Shares Subscribed	Subscription Amount (HKD)
1 lots	50	HK$ 4,140
2 lots	100	HK$ 8,280
3 lots	150	HK$ 12,420
4 lots	200	HK$ 16,560
5 lots	250	HK$ 20,700
6 lots	300	HK$ 24,840
7 lots	350	HK$ 28,980
8 lots	400	HK$ 33,120
9 lots	450	HK$ 37,260
10 lots	500	HK$ 41,400
12 lots	600	HK$ 49,680
14 lots	700	HK$ 57,960
16 lots	800	HK$ 66,240
18 lots	900	HK$ 74,520
20 lots	1,000	HK$ 82,800
30 lots	1,500	HK$ 124,200
40 lots	2,000	HK$ 165,600
50 lots	2,500	HK$ 207,000
60 lots	3,000	HK$ 248,400
70 lots	3,500	HK$ 289,800
80 lots	4,000	HK$ 331,200
90 lots	4,500	HK$ 372,600
100 lots	5,000	HK$ 414,000
120 lots	6,000	HK$ 496,800
140 lots	7,000	HK$ 579,600
160 lots	8,000	HK$ 662,400
180 lots	9,000	HK$ 745,200
200 lots	10,000	HK$ 828,000
400 lots	20,000	HK$ 1,656,000
600 lots	30,000	HK$ 2,484,000
800 lots	40,000	HK$ 3,312,000
1,000 lots	50,000	HK$ 4,140,000

Pool B

Lots Subscribed	Shares Subscribed	Subscription Amount (HKD)
1,400 lots	70,000	HK$ 5,796,000
1,600 lots	80,000	HK$ 6,624,000
1,800 lots	90,000	HK$ 7,452,000
2,000 lots	100,000	HK$ 8,280,000
4,000 lots	200,000	HK$ 16,560,000
7,036 lots	351,800	HK$ 29,129,040

Valuation & Financials

Market Cap (at Offer Price)	To be extracted
Pre-IPO Valuation (Last Round)	To be extracted
P/E Ratio	To be extracted
Profit/Loss Status	To be extracted
Period-End Cash Balance	To be extracted
Listing Expenses	To be extracted
Listing Expenses / Funds Raised	To be extracted
Total Pre-IPO Investment	To be extracted

First Day Performance

First Day Close	HK$ 87.0
First Day Open	HK$ 89.75
First Day Change	5.07%
First Day Volume	520446.0
First Day Turnover	45709400.0

Use of Proceeds

Use of Proceeds	1、約32.4%（即164.0百萬港元）將用于投資研發，以不斷加強公司的核心能力； 2、約26.6%（即135.0百萬港元）將用于通過升級現有產品及開發新產品進一步豐富公司的產品及服務； 3、約24.7%（即125.1百萬港元）將用于加強商業化能力并擴展公司的服務網絡； 4、約6.4%（即32.3百萬港元）將用于收購可能與公司現有產能產生協同效應的公司； 5、約10.0%（即50.7百萬港元）將用于營運資金及其他一般企業用途。

1、約32.4%（即164.0百萬港元）將用于投資研發，以不斷加強公司的核心能力； 2、約26.6%（即135.0百萬港元）將用于通過升級現有產品及開發新產品進一步豐富公司的產品及服務； 3、約24.7%（即125.1百萬港元）將用于加強商業化能力并擴展公司的服務網絡； 4、約6.4%（即32.3百萬港元）將用于收購可能與公司現有產能產生協同效應的公司； 5、約10.0%（即50.7百萬港元）將用于營運資金及其他一般企業用途。

Underwriting Syndicate

Joint Sponsors (3)

华泰金融控股（香港）有限公司 CE AOK809 广发融资（香港）有限公司 CE AOB163 建银国际金融有限公司 CE AJO225

Sponsor cum Overall Coordinator (1)

华泰金融控股（香港）有限公司 CE AOK809

Overall Coordinators (3)

华泰金融控股（香港）有限公司 CE AOK809 广发证券（香港）经纪有限公司建银国际金融有限公司 CE AJO225

Joint Global Coordinators (3)

华泰金融控股（香港）有限公司 CE AOK809 广发证券（香港）经纪有限公司建银国际金融有限公司 CE AJO225

Joint Bookrunners (9)

华泰金融控股（香港）有限公司 CE AOK809 广发证券（香港）经纪有限公司建银国际金融有限公司 CE AJO225 工银国际证券有限公司 CE ARO299 浦银国际融资有限公司 CE BFZ375 民银证券有限公司 CE APU820 农银国际融资有限公司 CE AWL249 中国银河国际证券（香港）有限公司 CE AXM459 TradeGo Markets Limited CE BRO637

Joint Lead Managers (10)

华泰金融控股（香港）有限公司 CE AOK809 广发证券（香港）经纪有限公司建银国际金融有限公司 CE AJO225 工银国际证券有限公司 CE ARO299 浦银国际融资有限公司 CE BFZ375 民银证券有限公司 CE APU820 农银国际证券有限公司 CE ACX411 中国银河国际证券（香港）有限公司 CE AXM459 TradeGo Markets Limited CE BRO637 宏智证券（香港）有限公司

Capital Market Intermediaries (11)

华泰金融控股（香港）有限公司 CE AOK809 广发证券（香港）经纪有限公司建银国际金融有限公司 CE AJO225 工银国际证券有限公司 CE ARO299 浦银国际融资有限公司 CE BFZ375 民银证券有限公司 CE APU820 农银国际融资有限公司 CE AWL249 农银国际证券有限公司 CE ACX411 中国银河国际证券（香港）有限公司 CE AXM459 TradeGo Markets Limited CE BRO637 宏智证券（香港）有限公司

Service Providers

Role	Institution
Legal Advisor to Company	高伟绅律师事务所上海澄明则正律师事务所 Pillsbury Winthrop Shaw Pittman LLP
Legal Advisor to Sponsors/Underwriters	欧华律师事务所金杜律师事务所
Auditor and Reporting Accountant	德勤•关黄陈方会计师行
Industry Advisor	弗若斯特沙利文（北京）咨询有限公司上海分公司
Compliance Advisor	新百利融资有限公司 CE BAU754
Receiving Banks	招商永隆银行有限公司

Cornerstone Investors

#	Investor Name	Investment Amount	Shares Subscribed	% of Offer Shares	% of Total Shares	Lock-up Period	Est. Unlock Date
1	Costone China Growth Capital I L.P.	62,240,760 HKD	—	10.68%	—	6 months	2025-06-30
2	达安投资有限公司	62,240,760 HKD	—	10.68%	—	6 months	2025-06-30
3	横琴粤澳深度合作区产业投资基金(有限合伙)	62,240,760 HKD	—	10.68%	—	6 months	2025-06-30
4	星群有限公司	27,998,820 HKD	—	4.81%	—	6 months	2025-06-30
5	讯医有限公司	61,996,500 HKD	—	10.64%	—	6 months	2025-06-30

Directors & Management

Chairman	劉慶峰
Company Secretary	劉偉;楊兆琳

No director data available.

Major Shareholders

Major Shareholders & Holdings	科大訊飛股份有限公司(49.42%),合肥正升信息科技合伙企業(有限合伙)(16.11%),安徽科訊創業投資基金合伙企業(有限合伙)(14.43%)

AI AI Analysis

Market Sentiment

The IPO saw tepid retail demand with an oversubscription ratio of just 3.66 times, far below typical Hong Kong market enthusiasm. This resulted in a hit rate of 89.99% (2,822 of 3,136 applications accepted), meaning nearly all applicants received shares. Such high allocation probability signals weak aftermarket sentiment expectations. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

An inefficiency appeared at the A/B boundary: the last A-tier application (50,000 lots) expected 1 lot, identical to the first B-tier application (70,000 lots). The extra 20,000 lots in B-head yielded no additional allocation, making A-tail more capital efficient. Broker fee considerations may further favor lower-tier applications, though actual costs vary. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Demographics

Mainland participants overwhelmingly dominated, comprising 82.4% of the 2,709 holders, highlighting strong domestic recognition for the AI healthcare brand. The investor base skewed male (63.8%) with an average age of 42.2, typical of tech-focused IPOs targeting experienced retail investors. Hong Kong residents accounted for just 17.2% of the total. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Subscription Tiers

IPO Timeline

讯飞医疗科技 02506Prospectus Information

Market Sentiment

Tier Analysis

Demographics